Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prism Medico & PharmacyBOM:512217 +1.72%54 PB Ratio is 1.17 as of Aug. 22, 2026, which is 9% above its 10-year median of 1.07. GuruFocus rates BOM:512217 with a GF Score™ of 54/100 and a GF Value™ of ₹28.00 (Fairly Valued). The stock has 7 warning signs investors should review. Among 1,896 Consumer Packaged Goods companies, Prism Medico & Pharmacy ranks better than 58.86% on this metric.
Prism Medico & Pharmacy Ltd stock PB Ratio (=1.17) is close to 3-year high of 1.29.
The historical rank and industry rank for Prism Medico & Pharmacy's PB Ratio or its related term are showing as below:
BOM:512217'
s PB Ratio Range Over the Past 10 Years
Min: 0.23 Med: 1.07 Max: 5.13
Current: 1.17
During the past 13 years, Prism Medico & Pharmacy's highest PB Ratio was 5.13. The lowest was 0.23. And the median was 1.07.
BOM:512217's PB Ratio is ranked better than 58.86% of 1896
companies
in the Consumer Packaged Goods industry
Industry Median: 1.41
vs BOM:512217: 1.17
During the past 12 months, Prism Medico & Pharmacy's average Book Value Per Share Growth Rate was 2.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 4.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -2.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Prism Medico & Pharmacy was 82.80% per year. The lowest was -25.30% per year. And the median was 0.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Farm Products subindustry, Prism Medico & Pharmacy's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prism Medico & Pharmacy PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Prism Medico & Pharmacy's PB Ratio distribution charts can be found below:
* The bar in red indicates where Prism Medico & Pharmacy's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Prism Medico & Pharmacy (BOM:512217) has a PB Ratio of 1.17 as of Aug. 22, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Prism Medico & Pharmacy and its competitors. This is near median its historical median of 1.07. Over the past decade, Prism Medico & Pharmacy's PB Ratio has ranged from 0.23 to 5.13. According to the industry distribution chart, Prism Medico & Pharmacy ranks #780 out of 1896 companies in the Consumer Packaged Goods industry, placing it in the top 41.1%.
Is Prism Medico & Pharmacy's PB Ratio too high?
Prism Medico & Pharmacy's current PB Ratio of 1.17 is near median its 10-year median of 1.07. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 5.13. The Consumer Packaged Goods industry median PB Ratio is 1.41. Prism Medico & Pharmacy's value of 1.17 is 17% below this industry median. Based on the distribution chart, Prism Medico & Pharmacy ranks #780 out of 1896 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Prism Medico & Pharmacy has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Prism Medico & Pharmacy's PB Ratio compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Prism Medico & Pharmacy ranks #780 out of 1896 companies for PB Ratio. This puts Prism Medico & Pharmacy in the upper half of its industry. The industry median PB Ratio is 1.41. Prism Medico & Pharmacy's value of 1.17 is 17% below this benchmark. Historically, Prism Medico & Pharmacy's own PB Ratio has ranged from 0.23 to 5.13 over the past decade. While the company's 10-year median is 1.07 vs. the industry median of 1.41, Prism Medico & Pharmacy has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.41, based on 1,896 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prism Medico & Pharmacy's current PB Ratio of 1.17 is 17% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Prism Medico & Pharmacy and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prism Medico & Pharmacy's current PB Ratio is 1.17, which is near median its own 10-year median of 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Medico & Pharmacy stock overvalued right now?
Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Fairly Valued. The stock's GF Value™ is ₹28.00, compared to a current price of ₹29.65 — trading 5.9% above its estimated fair value. The current PB Ratio is 1.17, which is near median its 10-year median of 1.07 and 17% below the Consumer Packaged Goods industry median of 1.41. Prism Medico & Pharmacy's overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current PB Ratio is 1.17 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?
Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be overvalued.
The current stock price of ₹29.65 is trading 5.9% above its estimated GF Value™ of ₹28.00.
GuruFocus considers Prism Medico & Pharmacy to be Fairly Valued.
Key valuation signals for BOM:512217:
PB Ratio: 1.17 (near median its 10-year median of 1.07)
GF Value™: ₹28.00 vs. price of ₹29.65 (5.9% above fair value)
Industry Position: 17% below the Consumer Packaged Goods median (#780 of 1896)
No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.
54GF Score
Get the complete analysis for BOM:512217
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512217 has been successfully added to your 
